| mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0056 |
0.9 |
| mRNA |
UNC0638 |
CTRPv2 |
pan-cancer |
AAC |
0.0057 |
0.9 |
| mRNA |
STF-31 |
CTRPv2 |
pan-cancer |
AAC |
-0.0055 |
0.9 |
| mRNA |
BRD-K07442505 |
CTRPv2 |
pan-cancer |
AAC |
-0.0058 |
0.9 |
| mRNA |
JQ-1:MK-0752 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0053 |
0.9 |
| mRNA |
EX-527 |
CTRPv2 |
pan-cancer |
AAC |
0.0057 |
0.9 |
| mRNA |
MI-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.0058 |
0.9 |
| mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.005 |
0.9 |
| mRNA |
BRD-K51831558 |
CTRPv2 |
pan-cancer |
AAC |
-0.0075 |
0.9 |
| mRNA |
PF-3758309 |
CTRPv2 |
pan-cancer |
AAC |
-0.006 |
0.9 |